[1]
F.C.Q.F.B., C. de I. del M. 2019. RISK OF NON-MELANOCYTIC CUTANEOUS CANCER FOR CONTINUOUS AND PROLONGED USE OF HYDROCLOROTIAZIDA. Bio Scientia. 2, 3 (Jun. 2019), 74–75.